GuidelineIndian pediatrics2026
Rational Allergy Practice Guidelines by the Indian Academy of Pediatrics (IAP) and IAP-Allergy and Applied Immunology Chapter.
Guideline in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRecognition of allergic diseases in children is on the rise globally, with a similar burden in lower-middle-income countries such as India. There is a lack of structured, context-specific guidelines and standardized care pathways for pediatric allergic diseases. This document aims to provide evidence-based, pragmatic guidance for rational allergy practice in children. JUSTIFICATION: Heterogeneous diagnostic approaches and non-uniform management practices for allergic conditions in children contribute to inaccurate disease burden estimation, inappropriate investigations, and suboptimal therapeutic outcomes, thereby increasing morbidity and healthcare costs. PROCESS: Key domains including asthma, allergic rhinitis, atopic dermatitis, food allergy, urticaria/angioedema, and anaphylaxis were identified. A multidisciplinary expert panel comprising pediatricians, pulmonologists, otorhinolaryngologists, clinical immunologists, internists, and allergists was constituted, with inputs from World Allergy Organization (WAO) Centers of Excellence and professional bodies. Systematic literature searches were conducted in Cochrane Library, Medline, Embase, and Google Scholar. Evidence was appraised and graded using established classification systems. Feasibility, equity, and resource implications relevant to India were considered, with provisions for periodic updates. RECOMMENDATIONS: These guidelines provide an evidence-based framework for rational diagnosis, judicious testing, standardized treatment, timely referral, patient and family education, rational allergen immunotherapy, and advocacy for training and policy development. They aim to standardize pediatric allergy care in India while supporting, not replacing, clinician judgment.
Indexed as
Identifiers
41949750What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.